icd10coded.com
  • ICD-10 CM
    • ICD-10 CM Diagnosis Codes
    • Convert ICD-9 to ICD-10
    • Index of Diseases and Injuries
    • Index of External Cause of Injuries
    • Table of Neoplasms
    • Table of Drugs & Chemicals
    • POA Reporting Guidelines
    • POA Codes
    • Diagnosis Related Groups - MS-DRG
  • ICD-10 PCS
    • ICD-10 PCS Procedure Codes
    • ICD-10 PCS Index
    • ICD-10 PCS Definitions
    • Device Aggregation Table
    • Diagnosis Related Groups - MS-DRG
  • Coding Rules
    • Perinatal/Newborn diagnoses
    • Pediatric diagnoses
    • Maternity diagnoses
    • Adult diagnoses
    • Diagnoses for females only
    • Diagnoses for males only
    • Procedures for females only
    • Procedures for males only
    • Unacceptable principal diagnosis
    • Questionable admission codes
    • Manifestation code as principal diagnosis
  • Clinical Concept
    • Allergy
    • Cardiology
    • Endocrinology
    • Family Practice
    • Internal Medicine
    • OB/GYN
    • Orthopedics
    • Pediatrics
    • Physical Therapy
  • Search
  1. Home
  2. ICD-10 CM
  3. E26.89
  4. Feedback

ICD-10 Code E26.89
Other hyperaldosteronism

E26.89 is a specific medical classification code under the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM), designated for other specified forms of hyperaldosteronism. Hyperaldosteronism is an endocrine disorder characterized by the excessive production of aldosterone, a steroid hormone synthesized by the adrenal glands that plays a critical role in regulating systemic blood pressure, sodium retention, and potassium excretion. When aldosterone levels are abnormally elevated, patients frequently develop secondary hypertension, hypokalemia, fluid retention, metabolic alkalosis, and associated clinical manifestations such as muscle weakness, fatigue, cardiac dysrhythmias, and headache. While common presentations like primary aldosteronism from an adrenal adenoma or secondary hyperaldosteronism from renal artery stenosis have distinct codes, E26.89 is assigned when a patient exhibits a documented, specified form of hyperaldosteronism that does not fit into standard primary, secondary, or congenital categories like Bartter syndrome. Related conditions and medical diagnoses that frequently overlap with or apply to this code include treatment-resistant hypertension, low serum potassium levels, renovascular hypertension, elevated renin-angiotensin system activity, and ectopic aldosterone-producing tumors.


E26.89 is a valid billable ICD-10 diagnosis code for Other hyperaldosteronism. It is found in the 2027 version of the ICD-10 CM Index and can be used in all HIPAA-covered transactions from Oct 01, 2026 - Sep 30, 2027.


MS-DRG - Medicare Severity-Diagnosis Related Group
  • MDC 10 Endocrine, Nutritional & Metabolic Diseases & Disorders
    Endocrine Disorders
    • DRG 643 - ENDOCRINE DISORDERS WITH MCC
    • DRG 644 - ENDOCRINE DISORDERS WITH CC
    • DRG 645 - ENDOCRINE DISORDERS WITHOUT CC/MCC

Coding structure:

ICD-10 code E26.89 is based on the following Tabular structure:

Chapter 4: Endocrine, nutritional and metabolic diseases
  • Section E20-E35: Disorders of other endocrine glands
    • Category E26: Hyperaldosteronism

↑ Parent code:
E26.8 for Other hyperaldosteronism

E26.89__
Category
 
Etiology, Anatomic Site,
Severity, Other Vital Details
Extension

Should you use E26.89 or E2689 (with or without decimal point) when submitting claims?

DO NOT include the decimal point when electronically filing claims as it may be rejected. Some clearinghouses may remove it for you but to avoid having a rejected claim due to an invalid ICD-10 code, do not include the decimal point when submitting claims electronically.

Section E20-E35 — Disorders of other endocrine glands

Excludes1

  • galactorrhea (N64.3)
  • gynecomastia (N62)
  1. E26 Hyperaldosteronism

    1. E26.0 Primary hyperaldosteronism

      1. E26.01 Conn's syndrome

      2. E26.02 Glucocorticoid-remediable aldosteronism

        Inclusion term(s):

        • Familial aldosteronism type I
      3. E26.09 Other primary hyperaldosteronism

        Inclusion term(s):

        • Primary aldosteronism due to adrenal hyperplasia (bilateral)
    2. E26.1 Secondary hyperaldosteronism

    3. E26.8 Other hyperaldosteronism

      1. E26.81 Bartter's syndrome

      2. E26.89 Other hyperaldosteronism

    4. E26.9 Hyperaldosteronism, unspecified

      Inclusion term(s):

      • Aldosteronism NOS
      • Hyperaldosteronism NOS
Abbreviations used here:

NEC Not elsewhere classifiable
This abbreviation in the Tabular List represents “other specified”. When a specific code is not available for a condition, the Tabular List includes an NEC entry under a code to identify the code as the “other specified” code.

NOS Not otherwise specified
This abbreviation is the equivalent of unspecified.

This note further define, or give examples of, the content of the code or category.

List of terms is included under some codes. These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of “other specified” codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.

Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, the ICD-10 CM has a coding convention that requires the underlying condition be sequenced first, if applicable, followed by the manifestation. Wherever such a combination exists, there is a “use additional code” note at the etiology code, and a “code first” note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation.

A type 1 Excludes note is a pure excludes. It means 'NOT CODED HERE!' An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.

A type 2 Excludes note represents 'Not included here'. An Excludes2 note indicates that the condition excluded is not part of the condition it is excluded from but a patient may have both conditions at the same time. When an Excludes2 note appears under a code it is acceptable to use both the code and the excluded code together.

A “code also” note instructs that two codes may be required to fully describe a condition, but this note does not provide sequencing direction. The sequencing depends on the circumstances of the encounter.

Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, the ICD-10 CM has a coding convention that requires the underlying condition be sequenced first, if applicable, followed by the manifestation. Wherever such a combination exists, there is a “use additional code” note at the etiology code, and a “code first” note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation.

Feedback

Finding the right ICD-10 code is not always easy. Submitting the wrong code can cause delays in processing claims and payments. Please let us know if there is anything we can do better to help make your job easier. We strive to be the best ICD-10 site possible.

Share this page

Was the information found on this page useful? Share this page with a friend or colleague. They may also find it useful. We can send an email to someone you designate with this information as well.

  • ICD-10 CM
  • ICD-10 PCS
  • FAQs
  • Sitemap
  • →
  • Terms of Use
  • Privacy Policy
  • Contact Us
Follow @icd10coded

ICD-10 data provided by CMS (Centers for Medicare & Medicaid Services). All content is provided “AS IS”. The latest version of ICD-10 is updated each year on October 1.

1.261103a — Privacy Settings